| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-08 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.3 | 3e-08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.28 | 5e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.26 | 1e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.27 | 4e-06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.83 | 0.0008 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0009 |